HSC‐engrafted NSG‐Tg(Hu‐IL15) mice that were treated with the NKp46 depleting antibody showed increased tumor growth kinetics as compared to isotype treated HSC‐engrafted NSG‐Tg(Hu‐IL15) mice (Figure 8B). Here, IL15 is linked to neoplasm.